Takeda Dengue Vaccine TAK-003 gets USFDA priority review Ruchika Sharma23 Nov 2022 5:00 PM ISTTakeda's tetravalent dengue vaccine candidate (TAK-003) is based on a live-attenuated dengue serotype 2 virus, which provides the genetic "backbone"...
Influenza vaccine guards against ischemic and hemorrhagic strokes: LANCET Dr. Kamal Kant Kohli18 Nov 2022 9:30 AM ISTCANADA: According to a study published in The Lancet Public Health, those who have recently received an influenza vaccination had a lower risk of...
Removing the HIGH from the OPIOID: Scientists develop Fentanyl Vaccine that prevents the opiod from entering the brain Dr. Kamal Kant Kohli17 Nov 2022 3:25 PM ISTA research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its...
Data-Driven scientific studies needed for Antimicrobial Resistance post COVID-19 pandemic Kajal Rajput14 Nov 2022 5:45 PM IST'India is providing 60% of generic drugs and 60% of total vaccines across the globe. Every 6th doctor and every 5th nurse is from India. Our...
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 1:30 PM ISTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU Ruchika Sharma13 Nov 2022 2:00 PM IST-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...
Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain Ruchika Sharma10 Nov 2022 10:00 AM ISTThe regulator on Wednesday also approved Novavax's COVID-19 shot as a booster for adults.
Monoclonal antibody may help prevent malaria infection in endemic region Dr. Kamal Kant Kohli9 Nov 2022 8:15 PM ISTOne dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali,...
Myocarditis Risk Two-Threefold Higher with Moderna Vaccine than Pfizer: JACC Study Kajal Rajput9 Nov 2022 8:00 PM ISTWASHINGTON: Choice of COVID-19 vaccine is indeed dependant on possiblities of side efffects associated with them A study published recently in the...
Moderna gets Health Canada authorization for second Omicron -targeting Bivalent booster Ruchika Sharma6 Nov 2022 4:30 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced Health Canada has...
Pfizer-BioNTech to test combined COVID, influenza vaccine Ruchika Sharma4 Nov 2022 3:40 PM ISTFrankfurt: Pfizer-BioNTech said they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better...
GSK gets USFDA priority review for RSV older adult vaccine Ruchika Sharma4 Nov 2022 12:15 PM ISTGSK’s RSV older adult vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with GSK’s proprietary...
